Recently, Rakovitch et al. [30] observed that women with a HER2+/Ki67+ DCIS had a higher risk of developing in situ local recurrence after breast-conserving surgery which is consistent with our results regarding HER2 status. This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.